Fragmented inactivated trivalent H7N9 influenza vaccine (Instituto Butantan)

N/A

Report date: 2023/01/08 19:06:09

Base Information

Drug NameFragmented inactivated trivalent H7N9 influenza vaccine (Instituto Butantan)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesInstituto Butantan

China Registration ClassN/A

Develop Information

Active CompaniesInstituto Butantan

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A